These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2720018)

  • 21. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
    Greden JF; Flegel P; Haskett R; Dilsaver S; Carroll BJ; Grunhaus L; Genero N
    Psychoneuroendocrinology; 1986; 11(2):195-204. PubMed ID: 3749402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoimmunoendocrine aspects of panic disorder.
    Brambilla F; Bellodi L; Perna G; Battaglia M; Sciuto G; Diaferia G; Petraglia F; Panerai A; Sacerdote P
    Neuropsychobiology; 1992; 26(1-2):12-22. PubMed ID: 1335559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA; Zitman FG; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Hoogendijk WJ; Smit JH; Penninx BW
    Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI; Pope HG; Jonas JM; Laffer PS; Hudson MS; Melby JC
    Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agoraphobia and the dexamethasone suppression test: atypical depression?
    Whiteford HA; Evans L
    Aust N Z J Psychiatry; 1984 Dec; 18(4):374-7. PubMed ID: 6596945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPA axis abnormalities in depressed patients with normal response to the DST.
    Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF
    Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E; Eskola J; Ruuskanen O; Laine T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 35. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM; Davis KL; Davis BM; Krieger DT
    Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dexamethasone suppression test in panic disorder: comparison with normal controls.
    Roy-Byrne PP; Bierer LM; Uhde TW
    Biol Psychiatry; 1985 Nov; 20(11):1237-40. PubMed ID: 4052520
    [No Abstract]   [Full Text] [Related]  

  • 37. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated dexamethasone suppression test in depressed patients.
    Maes M; De Ruyter M; Hobin P; Suy E
    J Affect Disord; 1986; 11(2):165-72. PubMed ID: 2948992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.